Previous Halal Digests

Halal Digest Header JUNE 2003
ISSN 1533-3361
In This Issue
Prescription Drugs - Brand or Generic Food News New Halal Certified Products

Alhamdulillah was-salatu was-salaamu 'ala rasoolillah. All thanks and praise is to ALLAH, Subhanahu wa ta'ala, and we ask that HIS blessings and peace be upon HIS Messenger, Muhammad, salla ALLAHu alaihi wa sallam. Capsule
Mortar and Pestle "Would you like me to fill that prescription with the generic equivalent?" "No thank you, I'll take the real thing." This unfortunate exchange occurs all too frequently in retail pharmacies bringing to mind the question, what is the "real thing"? Is opting for a generic equivalent to your prescription medication the same as opting for a generic detergent or generic paper plates? The answer, in a word, is NO.

To be marketed in the United States, all prescription drugs must be approved by the Food and Drug Administration (FDA) as safe and effective. This means a drug company or whoever discovers the new drug entity, must first file a new drug application (NDA) with the FDA. Once the NDA is accepted, the drug company may begin trials on animals and finally humans to prove the safety and effectiveness of the drug. Upon proving the safety and efficacy of the drug, the discovering company is granted permission by the FDA to market the drug under the brand (proprietary) name. In addition to granting permission to market the new drug, the FDA also grants a period of exclusivity to the discovering manufacturer. This means that for a specified number of years (usually between 4 and 7) no other company is allowed to manufacture the new drug. There are several reasons for exclusivity, the most significant of which is to maintain the incentive for pioneering companies to continue researching and discovering new drug entities.

During the period of exclusivity, other drug companies are itching to reproduce the newly approved drug because the legwork has already been done. The manufacturer that submits the NDA has already spent enormous amounts of money in research to bring the product to market. The company marketing the generic product, on the other hand, is only required to submit an abbreviated new drug application (ANDA), which does not require them to reprove what the pioneer manufacturer has already proven i.e., the efficacy of the drug entity. The generic company therefore saves millions of dollars in research and development as they are simply duplicating what has already been done. This savings allows the generic drug manufacturer to market the drug at a much lower price than that charged by the original manufacturer.

Capsules Having said that, not all drugs approved as generics are equivalent to the original drug entity. For this reason the FDA has established a rating system to determine the equivalence of generic drugs to the standard (original drug entity). Without going into great detail, I will suffice it to say that drugs rated AB are determined to be equivalent in all ways to the original drug. This means that taking one tablet of the generic drug will produce the same blood concentration, elimination rate and efficacy as the original drug +/- 5% (which is an insignificant difference for a majority of drugs).

For a minority of drug products termed "narrow therapeutic index" drugs (including but not limited to levothyroxine, phenytoin, warfarin, theophylline, lithium, digoxin, etc.) an AB rating means the generic product is as safe and effective as the brand, however these drugs require close monitoring by the physician. In other words patients on these drugs (brand or generic) must have blood levels drawn at various intervals to assure the blood concentration of these medications is not a toxic one, as narrow therapeutic index means that the window between an effective dose and a toxic dose of these medications is very small. In other words, when switching from brand to generic or vice versa one must have their dose reassessed by the physician. You might ask, "If these drugs are equivalent, why is it necessary to reassess the dose when switching between them?" This is because all individuals absorb, metabolize and eliminate drugs at a slightly different rate based on their unique physiology, so although the drugs are just as safe and effective, the slightest variation in absorption, metabolism or elimination may have a larger impact on blood concentration of narrow therapeutic index drugs.

Medicine The bottom line is that an AB rated generic drug has been proven by the FDA to be equivalent to the original brand name product and with the exception of the narrow therapeutic index drugs can be interchanged with the same expectations as the more expensive brand name product. In the face of ever increasing health care costs, one cannot afford to opt for a more expensive brand of the same AB rated medication when there is no therapeutic benefit to be expected from that product. Insurance companies have also begun to recognize generics as a prime candidate for cutting healthcare costs by shifting some of the burden to the consumer who chooses brand when an equivalent generic is available. Capsule


(This article was contributed by Feisal Rauhi Othman, Pharm.D., R.Ph.)

Back To Top
Halal Food Conference 2003 comng to Chicago on July 11, 2003 Halal Food Conference 2003 is coming to the Palmer House Hilton in Chicago, Illinois, USA on July 11, 2003. The Theme of the conference will be THE IMPORTANCE OF HALAL CERTIFICATION. Click here for more information or a registration form.
Newspaper An effort to start a Halal meat processing plant in Faribault, Minnesota is being held up by residents who object to the plant in their community. Despite completing an environmental assessment worksheet, a process rarely required for plants of this size, approval to establish the plant has not been granted. The opposition say the plant could damage the environment, lower property values and increase traffic in the area. The plant will attract jobs to the area. (There are over 250 slaughter plants in the state of Minnesota.) (Reported in Agri News on May 20, 2003.)
Newspaper The White House Office of Management and Budget would like to see more emphasis placed on eating foods with omega-3 fats and warn against eating foods with trans fatty acids. (Reported on on May 29, 2003.) Capsule

Back To Top
Crescent M, IFANCA Halal Certification Mark The following are new additions to the IFANCA Halal Certified Products. For more information, check out the entire listing of retail IFANCA Halal Certified Products. Please note, not all the products produced by these companies are certified Halal. Only those listed below are certified Halal.


The retail Halal Certified Product Additions are:

Product Produced By Available In
These Markets
Potato - Onion/Garlic
Soy Cyber Chips - Apple Cinnamon
Soy Cyber Chips - Original
Soy Cyber Chips - Roasted Toasted Garlic & Onion
Ideal Snacks
New York, USA
Nu Science Corporation
California, USA
Green's Premium Brand Ice Cream in the following flavors:
Black Raspberry Blast
Chocolate + Vanilla
Chocolate Caramel Malt Madness
Chocolate Chip Cookie Dough
Chocolate Marshmallow Swirl
Coconut Cream Pie
Colombian Coffee Chip
Cookies n Cream
Cotton Candy Confetti
Egg Nog
French Vanilla
Just Peachy
Metropolitan Neapolitan
Mint Chocolate Chip
Peanut Butter Twirl
Philly Vanilla Bean
Pocono Paws
Positively Peppermint
Southern Butter Pecan
Vanilla Fudge Swirl
Whitehouse Cherry

SK Brand Ice Cream in the following flavors:
Vanilla Fudge Twirl

Crowley Foods, LLC
New York, USA

IFANCA welcomes these companies to the family of Halal Certified Product Producers. Capsule

Back To Top

Halal Videos